Zhao Zhiming

Chinese People's Liberation Army

Papers

1

Total Citations

40

H-Index

1

About

Dr. Zhao Zhiming is a leading figure in minimally invasive pancreatic surgery, with a focused expertise in robotic and laparoscopic approaches for pancreatic ductal adenocarcinoma (PDAC). His major contributions center on rigorously comparing the short- and mid-term outcomes of robotic versus laparoscopic distal pancreatosplenectomy (DPS), a technically demanding procedure for PDAC. In his highly cited 2018 retrospective propensity score-matched study—which has garnered 40 citations—Dr. Zhao demonstrated that robotic DPS offers significant short-term benefits over the laparoscopic approach, including reduced blood loss and faster recovery, without compromising oncologic outcomes. This work has been instrumental in advancing the adoption of robotic techniques for PDAC, a field where minimally invasive surgery has historically faced skepticism. Dr. Zhao’s research provides critical evidence that robotic DPS is both safe and effective, helping to shift clinical practice toward less invasive options for patients with pancreatic cancer. His findings continue to influence surgical decision-making and inspire further prospective studies, solidifying his reputation as a pioneer in robotic pancreatic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
40
Total Citations
40
Avg Citations/Paper
🏆 Most Cited Paper
Short- and mid-term outcomes of robotic versus laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma: A retrospective propensity score-matched study
40 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Chinese People's Liberation Army

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago